Navigation Links
A critical moment in the field of lung cancer
Date:3/4/2010

Rapid advances in drug development, genetics and multidisciplinary treatment have brought the field of oncology to a critical moment, says Dr. Rafael Rosell from the Catalan Institute of Oncology in Badalona, Spain, co-chair of the second European Lung Cancer Conference (ELCC), which will be held in Geneva, Switzerland from 28 April to 1 May 2010.

More than 1,500 delegates are expected at the conference, which is a joint initiative of the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC).

"Recognized as the leading force of medical oncology in Europe, ESMO is partnering with key associations to provide the oncology community with the best knowledge in selected areas, including lung cancer," said Dr. Rolf Stahel, Chair of the ESMO Educational Committee.

"The International Association for the Study of Lung Cancer is the world's largest professional organization solely dedicated to reducing the burden of lung cancer and other thoracic malignancies. Educational programs are one way in which we accomplish this goal. We are proud to work jointly with ESMO in Europe to sponsor the largest European meeting on lung cancer," said Dr. Paul Bunn, IASLC Executive Director.

The event program will build on the success of the first European Lung Cancer Conference, which was held in 2008. Cutting-edge data on experimental new drugs, improvements in diagnosis and advances in treatment will be complemented by sessions on important topics presented by the world's leading authorities and debates on controversial topics. Dr. Ala Din Alwan, WHO Assistant Director-General for Non-Communicable Diseases and Mental Health, will address the opening session of the conference.

Media representatives are welcome to register and attend the second ELCC. A fully equipped press room will be available on-site. For those who cannot attend in person, the organizers are happy to provide full assistance with arranging phone interviews with speakers or other experts. Media information on the most interesting studies presented at the conference will be released in the following weeks.

Lung cancer, a disease that kills 1.5 million people each year, is among the most challenging cancers to treat. But new advances are improving the chances of a better outcome.

"This is a critical moment in the field of lung cancer," said conference co-chair Dr. Franoise Mornex from Centre Hospitalier Lyon Sud in France. "At the conference, leading experts from around the world will report on new strategies for multidisciplinary approaches and the latest pharmacogenomic research and clinical trials on topics such as genetic assessment of patients."


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. gloStream Presentation to Focus on Microsoft Platform's Critical Role in EHR Development and Patient Information Access and Portability
2. Guardian Offers Critical Illness Insurance Advice
3. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
4. Biomedical Industry Jobs Critical to California's Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers
5. Caregivers of ICU patients are collateral damage of critical illness, say Pitt researchers
6. Congress Urged to Take Immediate Action to Ensure Frail Patients Continue to Receive Critical Therapy Services
7. In Earthquake Aftermath, Response Time is Critical: How MEDEX Global Solutions Protected Clients and Travelers
8. Scientists discover cells critical to childhood leukemia
9. Disclosing sexual abuse is critical
10. Huntington Hospital Uses New Technology to Assist Nurses; Voalte iPhone Application Improves Critical Communication at Point-of-Care
11. Studies Show Doctors Rapidly Forget Critical, Life-Saving Skills such as CPR and Life Support
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... Flottman ... and outserts. As a means of expanding capabilities Flottman has added a ... to individually code professional inserts (PIs) and patient package inserts (PPIs) that will ...
(Date:12/9/2016)... , ... December 09, 2016 , ... An inventor from ... to safely ride all types of amusement park rides. , The patent-pending SAFETY STRAP ... is easy to use and could be set up in a matter of minutes, ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying ... Va. "I thought that if the nebulizer had a more child-friendly design, then children ... , He developed the patent-pending NEBY to avoid the need to deliver medication via ...
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec 9, 2016 Research ... Screening Market - Forecast to 2021" report to their ... ... of open innovative models in the pharmaceutical and biotechnology industry ... and rising government funding. Emerging markets and growing research activities ...
(Date:12/9/2016)...  RxWiki Inc., a digital health company that powers ... thousands of pharmacies through its Digital Pharmacist SaaS platform, ... "50 on Fire" Award in the Health and Life ... the award as one of Austin,s fastest growing companies," ... RxWiki. "Our platform gives independent retail pharmacies the digital ...
(Date:12/9/2016)... , Dec. 9, 2016  Forge Therapeutics, ... AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) ... ,LpxC, for the treatment of bacterial infections including ... been recognized as an attractive antibacterial target for ... lack of suitable chemical starting points has hampered ...
Breaking Medicine Technology: